Q1 EPS Estimate for Corbus Pharmaceuticals Lifted by Analyst
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – HC Wainwright boosted their Q1 2025 EPS estimates for shares of Corbus Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the biopharmaceutical company will post earnings per share of ($0.98) for the […]
More Stories
30-Year Fixed-Rate Mortgage Rate Hits 7.4 percent
By Naveen Athrappully The average weekly rate on a 30-year fixed-rate mortgage hit 7.4 percent, according to a Oct. 8...
US Issues Security Alert to Citizens in Middle East After Houthis Attack Saudi Arabia
By Aldgra Fredly The United States warned American citizens in the Middle East to remain vigilant on Thursday after Yemen’s...
Americans’ Incomes, Net Worth Climbed in Post-Pandemic Years: Federal Reserve
By Andrew Moran Americans’ incomes and net worth rose in the years after the pandemic, the Federal Reserve said in...
Judge Bars Deportation of Illegal Immigrant Shot by ICE in New York
By Aldgra Fredly A federal judge barred the Trump administration from deporting a Dominican immigrant who was shot by a...
‘It’s Time for Ukraine to Get a New President,’ Trump Says
By Timothy Frudd U.S. President Donald Trump suggested on Oct. 10 that Ukraine needs a new leader, one day after...
UAE Prosecutor Says Flydubai Co-Pilot Drifted Toward Extremism While in Australia
By Aldgra Fredly The co-pilot who allegedly attempted to hijack a Flydubai flight on Sept. 30 drifted toward extremism and...